Tag: Fusion Pharmaceuticals Inc

A potential $25 billion market opportunity for the emerging cancer treatment

Big pharma is making big investments in the field of targeted radiopharmaceutical therapy, which delivers radiation directly into tumors by attaching radioactive particles to targeting molecules. This emerging class of cancer treatments has caught the attention of Wall Street, with RBC Capital Markets estimating a $25 billion market opportunity. Novartis, a market leader in targeted […]

Back To Top